KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
| Catalog Number | YR1118 |
|---|---|
| Product Name | Anti-Human CD262 Recombinant Antibody(Lexatumumab) |
| Molecular Name | Lexatumumab |
| Alias | Anti-CD262 Recombinant Antibody, Research Grade Lexatumumab |
| CAS Number | 845816-02-6 |
| Target | CD262[Homo sapiens] |
| Isotype | IgG1 Lambda |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Applications | ELISA, IP, FCM, FuncS, Neut, IF |
| Buffer | PBS, pH7.5 |
| Background | Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment of cancer. HGS-ETR2 antibodies were generated by Human Genome Sciences through a collaboration with Cambridge Antibody Technology. Development was discontinued in 2015. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：info@kmdbioscience.com
Hot Line： +1-315-239-3085
Technical Support：sales@kmdbiosci.com
